Menu Back toMarket Access, Medical Affairs, and Regulatory Affairs Functions Working Together to Address Payor and Regulatory Requirements

DIA 2021 Global Annual Meeting


Market Access, Medical Affairs, and Regulatory Affairs Functions Working Together to Address Payor and Regulatory Requirements

Session Chair(s)

Todd  Paporello, PharmD, MBA

Todd Paporello, PharmD, MBA

  • Vice President and Head of Regulatory Affairs Americas
  • Bayer, United States
Drug development is evolving to address payor and regulatory requirements. Market access, medical affairs, and regulatory affairs functions are working together in this complex payor and regulatory ecosystem to sustain patient access to medicine.
Learning Objective : Summarize how the market access, medical affairs, and Regulatory Affairs functions within a pharmaceutical company are working together differently now then they have in the past to address both payor and regulatory requirements; Name the ways the drug development is evolving to ensure clinical trials are addressing coverage and regulatory decisions.

Speaker(s)

I-Fen  Chang, PharmD

Industry Perspective

I-Fen Chang, PharmD

  • Vice President, Head of Oncology Global Medical
  • Amgen, United States
Todd  Paporello, PharmD, MBA

Industry Perspective

Todd Paporello, PharmD, MBA

  • Vice President and Head of Regulatory Affairs Americas
  • Bayer, United States
Cindy  McDonald-Everett

Industry Perspective

Cindy McDonald-Everett

  • Senior Vice President, Global Value Access
  • Seagen, United States